USFDA nod to Eli Lilly Olumiant for certain hospitalized Covid patients Ruchika Sharma13 May 2022 1:02 PM ISTOLUMIANT is a once-daily, oral JAK inhibitor discovered by Incyte and licensed to Lilly.
Eli Lilly appoints Mary Lynne Hedley to its Board Ruchika Sharma8 May 2022 11:00 AM ISTIndianapolis: The Board of Directors of Eli Lilly and Company has elected Mary Lynne Hedley, Ph.D., as a new member, effective May 15, 2022. As a...
Setback: Eli Lilly- Innovent lung cancer drug Sintilimab rejected by USFDA Ruchika Sharma26 March 2022 12:41 PM ISTFDA and its advisers had raised concerns over the lack of population diversity in a single-country trial.
Eli Lilly, Boehringer Ingelheim gets USFDA nod for Jardiance to treat heart failure regardless of ejection fraction MD Bureau26 Feb 2022 11:00 AM ISTIndianapolis: Eli Lilly and Company and Boehringer Ingelheim have recently announced that the U.S. Food and Drug Administration (USFDA) has...
Eli Lilly launches Institute for Genetic Medicine MD Bureau26 Feb 2022 9:00 AM ISTThrough the work of the Institute, Lilly intends to fuel the development of gentic medicines, which already account for more than 20 percent of...
Eli Lilly, RosVivo Therapeutics ink pact for diabetes treatment MD Bureau23 Feb 2022 2:20 PM ISTSeoul: RosVivo Therapeutics, Inc. has announced that the company has signed a Material Transfer Agreement (MTA) with Eli Lilly and Company for...
Eli Lilly bags USFDA emergency use nod for COVID drug Bebtelovimab Ruchika Sharma12 Feb 2022 2:52 PM ISTIndianapolis: Eli Lilly has recently announced that the company has received the Emergency Use Authorization (EUA) from the U.S. Food and Drug...
USFDA halts use of Regeneron, Lilly Covid-19 antibody treatments Ruchika Sharma25 Jan 2022 11:52 AM ISTNew Delhi: The U.S. health regulator revised on Monday the emergency use authorizations for COVID-19 antibody treatments from Regeneron and Eli...
Experimental Lilly drug neutralizes Omicron in lab; slightly higher risk of diabetes seen in kids after COVID Ruchika Sharma12 Jan 2022 1:15 PM ISTA spokesperson for Eli Lilly said the company is "urgently working with the FDA to make bebtelovimab available under an emergency use authorization...
Lilly Partners with Canadian Pharma Company for therapies for multiple neurologic conditions Medical Dialogues Bureau9 Jan 2022 1:45 PM ISTNDIANAPOLIS - Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has inked a research and collaboration agreement with Entos Pharmaceuticals in Canada....
Vineet Gupta appointed as GM of Eli Lilly India affiliate Ruchika Sharma9 Dec 2021 1:25 PM ISTNew Delhi: Eli Lilly and company (India) has announced the appointment of Vineet Gupta as the General Manager of its India subsidiary with effect...
USFDA expands EUA for Eli Lilly bamlanivimab with etesevimab Ruchika Sharma5 Dec 2021 10:30 AM ISTIndianapolis: Eli Lilly has recently announced that U.S. Food and Drug Administration (USFDA) has expanded the Emergency Use Authorization...
